Dofetilide is a class III antiarrhythmic agent that is approved by the Food and Drug Administration (FDA) for the maintenance of sinus rhythm in individuals prone to the formation of atrial fibrillation and flutter, and for the chemical cardioversion to sinus rhythm from atrial fibrillation and flutter.
用于心房扑动、心房颤动、室上性心动过速。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.